A Therapeutic System of 177Lu-labeled Gold Nanoparticles-RGD Internalized in Breast Cancer Cells

被引：0
|
作者：
Luna-Gutierrez, Myrna [1 ,2 ]
Ferro-Flores, Guillermina [1 ]
Ocampo-Garcia, Blanca E. [1 ]
Santos-Cuevas, Clara L. [1 ]
Jimenez-Mancilla, Nallely [1 ,2 ]
De Leon-Rodriguez, L. M. [3 ]
Azorin-Vega, Erika [1 ]
Isaac-Olive, Keila [2 ]
机构：
[1] Inst Nacl Invest Nucl, Dept Mat Radiactivos, Toluca, Estado De Mexic, Mexico
[2] Univ Autonoma Estado Mexico, Fac Med, Toluca, Estado De Mexic, Mexico
[3] Univ Guanajuato, Dept Quim, Guanajuato, Mexico
来源：
JOURNAL OF THE MEXICAN CHEMICAL SOCIETY | 2013年 / 57卷 / 03期
关键词：
gold nanoparticles; radiolabeled nanoparticles; radio-gold nanoparticles; radiolabeled peptides; nanoparticle-peptide; RGD peptide; lutetium-177; IN-VITRO; PEPTIDES; LIGANDS;
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
The aim of this research was to evaluate the in vitro potential of Lu-177-labeled gold nanoparticles conjugated to cyclo-[RGDfK(C)] peptides (Lu-177-AuNP-c[RGDfK(C)]) as a plasmonic photothermal therapy and targeted radiotherapy system in MCF7 breast cancer cells. Peptides were conjugated to AuNPs (20 nm) by spontaneous reaction with the thiol group of cysteine (C). After laser irradiation, the presence of c[RGDfK(C)]-AuNP in cells caused a significant increase in the temperature of the medium (50.5 C, compared to 40.3 C without AuNPs) resulting in a significant decrease in MCF7 cell viability down to 9 %. After treatment with Lu-177-AuNP-c[RGDfK(C)], the MCF7 cell proliferation was significantly inhibited.
引用
收藏
页码：212 / 219
页数：8
相关论文
共 50 条
  • [21] 177Lu-Labeled and Trastuzumab-Conjugated Gold Nanoparticles Exhibit Multivalent Binding, High Uptake and Retention in HER2-Positive Breast Cancer Cells and Potent Cytotoxicity
    Cai, Z.
    Yook, S.
    Lu, Y.
    Winnik, M. A.
    Pignol, J.
    Reilly, R. M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S530 - S530
  • [22] Tracer level radiochemistry to clinical dose preparation of 177Lu-labeled cyclic RGD peptide dimer
    Chakraborty, Sudipta
    Sarma, H. D.
    Vimalnath, K. V.
    Pillai, M. R. A.
    NUCLEAR MEDICINE AND BIOLOGY, 2013, 40 (07) : 946 - 954
  • [23] 177Lu-labeled monomeric, dimeric and multimeric RGD peptides for the therapy of tumors expressing a(?)ß(3) integrins
    Luna-Gutierrez, Myrna
    Ferro-Flores, Guillermina
    Ocampo-Garcia, Blanca
    Jimenez-Mancilla, Nallely
    Morales-Avila, Enrique
    De Leon-Rodriguez, Luis
    Isaac-Olive, Keila
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2012, 55 (04): : 140 - 148
  • [24] A comparison of EGFR-targeted and non-targeted 177Lu-labeled gold nanoparticles (AuNPs) for localized radiation treatment of breast cancer xenografts in athymic mice
    Yook, S.
    Cai, Z.
    Lu, Y.
    Pignol, J.
    Winnik, M. A.
    Reilly, R. M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S296 - S296
  • [25] Optimized Therapeutic 177Lu-Labeled PSMA-Targeted Ligands with Improved Pharmacokinetic Characteristics for Prostate Cancer
    Wu, Yitian
    Zhang, Xiaojun
    Duan, Xiaojiang
    Yang, Xing
    Wang, Feng
    Zhang, Jinming
    PHARMACEUTICALS, 2022, 15 (12)
  • [26] Assessment of 177Lu-labeled carboxyl-terminated polyamidoamine (PAMAM) dendrimer-RGD peptide conjugate
    Vats, Kusum
    Sharma, Rohit
    Sharma, Amit Kumar
    Sarma, Haladhar D.
    Satpati, Drishty
    JOURNAL OF PEPTIDE SCIENCE, 2022, 28 (02)
  • [27] 177Lu-labeled cyclic RGD peptide as an imaging and targeted radionuclide therapeutic agent in non-small cell lung cancer: Biological evaluation and preclinical study
    Pirooznia, Nazanin
    Abdi, Khosrou
    Beiki, Davood
    Emami, Farshad
    Arab, Seyed Shahriar
    Sabzevari, Omid
    Soltani-Gooshkhaneh, Samira
    BIOORGANIC CHEMISTRY, 2020, 102
  • [28] Theranostic role of89Zr/177Lu-labeled aflibercept in triple-negative breast cancer
    Kang, L.
    Yang, Q.
    Chen, Z.
    Qiu, Y.
    Huang, W.
    Song, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S282 - S283
  • [29] Therapeutic Efficacy of 177Lu-Labeled A20FMDV2 Peptides Targeting ανβ6
    Huynh, Truc Thao
    Sreekumar, Sreeja
    Mpoy, Cedric
    Rogers, Buck Edward
    PHARMACEUTICALS, 2022, 15 (02)
  • [30] On the preparation of a therapeutic dose of 177Lu-labeled DOTA-TATE using indigenously produced 177Lu in medium flux reactor
    Das, Tapas
    Chakraborty, Sudipta
    Banerjee, Sharmila
    Venkatesh, Meera
    APPLIED RADIATION AND ISOTOPES, 2007, 65 (03) : 301 - 308
12345